Growing community of inventors

St. Laurent, Canada

Gregory Moeck

Average Co-Inventor Count = 2.95

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Gregory MoeckThomas R Parr, Jr (5 patents)Gregory MoeckDario Lehoux (3 patents)Gregory MoeckAdel Rafai Far (1 patent)Gregory MoeckThomas R Parr (5 patents)Gregory MoeckPierre Etienne (2 patents)Gregory MoeckAdam Belley (1 patent)Gregory MoeckSylvain Beaulieu (1 patent)Gregory MoeckFrancis Arhin (1 patent)Gregory MoeckEve Neesham-Grenon (1 patent)Gregory MoeckThomas Reeves Parr (1 patent)Gregory MoeckGeoffrey Mckay (0 patent)Gregory MoeckThomas Reeves Parr (0 patent)Gregory MoeckGregory Moeck (6 patents)Thomas R Parr, JrThomas R Parr, Jr (8 patents)Dario LehouxDario Lehoux (6 patents)Adel Rafai FarAdel Rafai Far (13 patents)Thomas R ParrThomas R Parr (5 patents)Pierre EtiennePierre Etienne (2 patents)Adam BelleyAdam Belley (2 patents)Sylvain BeaulieuSylvain Beaulieu (1 patent)Francis ArhinFrancis Arhin (1 patent)Eve Neesham-GrenonEve Neesham-Grenon (1 patent)Thomas Reeves ParrThomas Reeves Parr (1 patent)Geoffrey MckayGeoffrey Mckay (0 patent)Thomas Reeves ParrThomas Reeves Parr (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The Medicines Company (4 from 26 patents)

2. Melinta Therapeutics, Inc. (2 from 24 patents)


6 patents:

1. 12514899 - Methods of treatment using single doses of oritavancin

2. 10201587 - Methods of inhibiting and treating biofilms using glycopeptide antibiotics

3. 9775878 - Methods for treating bacterial infections using oritavancin and polymyxins

4. 9682061 - Methods of treating bacterial infections using oritavancin

5. 9089507 - Use of oritavancin for prevention and treatment of anthrax

6. 8420592 - Methods of treatment using single doses of oritavancin

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/6/2026
Loading…